Novel Target and Lead Packages for Diverse Indications

View All Products

To facilitate the rapid progression of novel new drugs into clinical trials, our group focuses on new mechanistic studies and lead compound development necessary for the initial phases of drug development. We work on key facets of drug development that include mechanistic studies disease indications, clinical validations, structural analyses, and biomarkers for lead compound development.


Devices, Kits and Instruments with Smart, Accurate, Fast, Economic Technologies


We're not around right now. But you can send us an email and we'll get back to you, asap.


©2010-2020 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?